ArticleTherapeutic advances in medical oncology2026

Efficacy of surufatinib in advanced Grade 3 neuroendocrine tumors: a real-world, national, multicenter study.

Jian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.